Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid
Ursolic acid (UA), a natural pentacyclic triterpenoid, possesses widespread biological and pharmacological activities. However, drawbacks such as low bioavailability, poor targeting and rapid metabolism greatly hinder its further clinical application. Recently, with the development of nanotechnology...
Saved in:
Main Authors: | Jingwei Shao (Author), Yifan Fang (Author), Ruirui Zhao (Author), Fangmin Chen (Author), Mingyue Yang (Author), Jiali Jiang (Author), Zixuan Chen (Author), Xiaotian Yuan (Author), Lee Jia (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoformulations of Ursolic Acid: A Modern Natural Anticancer Molecule
by: Longyun Wang, et al.
Published: (2021) -
Ursolic acid induces apoptosis and anoikis in colorectal carcinoma RKO cells
by: Jia-Lu Zheng, et al.
Published: (2021) -
Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy
by: Fangmin Chen, et al.
Published: (2021) -
Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid in vitro and in vivo
by: Weijie Li, et al.
Published: (2019) -
Kinetic disposition of ursolic acid in rats
by: Rosangela Peccinini, et al.
Published: (2018)